Skip to content

Pinnacle Multi-Programmable Pacing Sys

by Cardio-Pace Medical, Inc.

510(k) K853771

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK853771 Date15 Jul 1986ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Pinnacle Multi-Programmable Pacing System is an implantable pacemaker pulse-generator designed to regulate heart rhythm by delivering electrical impulses to the heart muscle. It is classified as a Class III medical device and is intended for patients requiring cardiac pacing to correct bradycardia or other conduction disorders.

This system is implanted surgically and is intended for single-patient use. It operates within MRI-safe parameters as defined by its specifications and is regulated under FDA 510(k) clearance (K853771) with a decision of Substantially Equivalent. The device is supplied sterile and requires proper storage to maintain functionality, adhering to standard implantable device protocols.

Other devices from Cardio-Pace Medical, Inc.

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of heart conditions is the Pinnacle Multi-Programmable Pacing System designed to treat, and how does it work?

    The Pinnacle Multi-Programmable Pacing System is intended for patients with bradycardia or conduction disorders, which cause an abnormally slow heart rate or improper electrical signaling in the heart. It works by delivering precise electrical impulses to the heart muscle through surgical implantation, helping to regulate and maintain a normal heart rhythm.

  • Is the Pinnacle Multi-Programmable Pacing System intended for reuse, or is it meant for single-patient use only?

    The device is explicitly designed for single-patient use only, meaning it is not intended to be reused after implantation in one individual. This aligns with standard practices for implantable pacemakers to ensure patient safety and sterility.

  • How should the Pinnacle Multi-Programmable Pacing System be stored to maintain its functionality and sterility?

    The device is supplied sterile and must be stored according to standard protocols for implantable medical devices. Proper storage conditions—such as maintaining dryness, avoiding extreme temperatures, and protecting from physical damage—are critical to preserve its functionality and sterility before implantation.

  • Can this pacemaker be used in patients who require MRI scans, and if so, what safety considerations apply?

    Yes, the Pinnacle Multi-Programmable Pacing System operates within MRI-safe parameters as defined by its specifications. However, MRI use should always follow the manufacturer’s guidelines and clinical protocols to ensure patient safety, as specific settings and precautions may apply depending on the MRI machine and scan parameters.

  • What regulatory pathway was followed for the FDA clearance of this device, and what does that mean for its safety and effectiveness?

    The device received FDA clearance through a 510(k) submission, classified as *Substantially Equivalent* (SESE) under the Traditional review pathway. This means the FDA determined that the Pinnacle system is at least as safe and effective as a legally marketed predicate device (an earlier pacemaker model) and meets applicable regulatory standards for implantable pacemakers.